Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BerGenBio ASA
Stanford University
Haihe Biopharma Co., Ltd.
Hoffmann-La Roche
INSYS Therapeutics Inc